CG Oncology (CGON) Net Margin (2023 - 2026)

CG Oncology posted quarterly Net Margin of 5549.49% for Q1 2026, up 6071397.0% year-on-year from N/an in Q1 2025, and down 212.34% on a QoQ basis from 1776.74% in Q4 2025.

CG Oncology (CGON) has 4 years of Net Margin data on file, last reported at 5549.49% in Q1 2026.

  • For the quarter ending Q1 2026, Net Margin rose 6071397.0% year-over-year to 5549.49%; the trailing twelve-month figure through Mar 2026 stood at 3677.52% (up 1226840.0% YoY), and the FY2025 full-year result was 3985.02%, up 374447.0% from the prior year.
  • Net Margin for Q1 2026 stood at 5549.49%, down from 1776.74% in the prior quarter.
  • Across five years, Net Margin topped out at 1776.74% in Q4 2025 and bottomed at 2249000.0% in Q4 2023.
  • The 4-year median for Net Margin is 6973.25% (2024), against an average of 236441.98%.
  • The widest annual swing landed in 2024, when Net Margin surged 224202675 bps; it then slumped 6306271 bps in 2025.
  • A 4-year view of Net Margin shows it stood at 2249000.0% in 2023, then soared by 100 bps to 6973.25% in 2024, then surged by 75 bps to 1776.74% in 2025, then sank by 212 bps to 5549.49% in 2026.
  • The last three Net Margin figures came in at 5549.49% (Q1 2026), 1776.74% (Q4 2025), and 2623.53% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.82%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 34.53%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 20.17%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 17.65%
10 CG Oncology 5.01 Bn 5.01 Bn -1.88 Mn -5,549.49%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -5,549.49%
Dec 31, 2025 -1,776.74%
Sep 30, 2025 -2,623.53%
Mar 31, 2025 -66,263.46%
Dec 31, 2024 -6,973.25%
Sep 30, 2024 -47,453.49%
Jun 30, 2024 -17,028.83%
Mar 31, 2024 -3,200.76%
Dec 31, 2023 -2,249,000.00%
Sep 30, 2023 -194,600.00%
Mar 31, 2023 -6,392.27%